This study attempted to (1) examine the relationship between DCE parameters and immunohistochemical indicators (CD34 and ki-67) in cervical cancer, (2) investigate the diagnostic performance of DCE parameters in differentiating cervical cancer and normal cervix tissue, and (3) evaluate the reproducibility of measured DCE parameters from various TKMs in cervical cancer patients using different scanners in a multicenter clinical setting. This evidence concerns the gene CD34 and cervical cancer.